TRex Bio, Inc.

TRXB Nasdaq SEC CIK 2139097
Follow TRex Bio Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$13.2M −68.4% vs same quarter last year
EPS, diluted −$10.06 −32.7% vs same quarter last year
Operating income −$13.9M −59.7% vs same quarter last year
Net income by quarter
−$9.4M
−$8.3M
−$7.9M
−$16.2M
−$13.1M
−$13.2M
Q1 25 Q2 25 Q3 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing